• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过深度学习算法对透明细胞肾细胞癌进行预后和免疫治疗反应的稳健预测。

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Immunol. 2022 Feb 7;13:798471. doi: 10.3389/fimmu.2022.798471. eCollection 2022.

DOI:10.3389/fimmu.2022.798471
PMID:35197975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8860306/
Abstract

It is of great urgency to explore useful prognostic markers and develop a robust prognostic model for patients with clear-cell renal cell carcinoma (ccRCC). Three independent patient cohorts were included in this study. We applied a high-level neural network based on TensorFlow to construct the robust model by using the deep learning algorithm. The deep learning-based model (FB-risk) could perform well in predicting the survival status in the 5-year follow-up, which could also significantly distinguish the patients with high overall survival risk in three independent patient cohorts of ccRCC and a pan-cancer cohort. High FB-risk was found to be partially associated with negative regulation of the immune system. In addition, the novel phenotyping of ccRCC based on the F-box gene family could robustly stratify patients with different survival risks. The different mutation landscapes and immune characteristics were also found among different clusters. Furthermore, the novel phenotyping of ccRCC based on the F-box gene family could perform well in the robust stratification of survival and immune response in ccRCC, which might have potential for application in clinical practices.

摘要

探索有用的预后标志物并为透明细胞肾细胞癌 (ccRCC) 患者开发稳健的预后模型迫在眉睫。本研究纳入了三个独立的患者队列。我们应用了基于 TensorFlow 的高级神经网络,通过深度学习算法构建稳健模型。基于深度学习的模型 (FB-risk) 可以很好地预测 5 年随访期间的生存状态,并且可以在三个独立的 ccRCC 患者队列和泛癌队列中显著区分高总体生存风险的患者。高 FB-risk 被发现与免疫系统的负调节部分相关。此外,基于 F-box 基因家族的 ccRCC 的新型表型可以稳健地区分具有不同生存风险的患者。还发现了不同簇之间不同的突变景观和免疫特征。此外,基于 F-box 基因家族的 ccRCC 的新型表型可以很好地对 ccRCC 的生存和免疫反应进行稳健分层,这可能具有在临床实践中的应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/db97f415812c/fimmu-13-798471-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/68a388e46f8a/fimmu-13-798471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/77f43ea9a2a3/fimmu-13-798471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/61d450f8afbc/fimmu-13-798471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/ad0861e8e1f7/fimmu-13-798471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/2b7ef44460c5/fimmu-13-798471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/49fc59198019/fimmu-13-798471-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/b1b656c352e1/fimmu-13-798471-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/db97f415812c/fimmu-13-798471-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/68a388e46f8a/fimmu-13-798471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/77f43ea9a2a3/fimmu-13-798471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/61d450f8afbc/fimmu-13-798471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/ad0861e8e1f7/fimmu-13-798471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/2b7ef44460c5/fimmu-13-798471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/49fc59198019/fimmu-13-798471-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/b1b656c352e1/fimmu-13-798471-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f807/8860306/db97f415812c/fimmu-13-798471-g008.jpg

相似文献

1
Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.通过深度学习算法对透明细胞肾细胞癌进行预后和免疫治疗反应的稳健预测。
Front Immunol. 2022 Feb 7;13:798471. doi: 10.3389/fimmu.2022.798471. eCollection 2022.
2
Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.大规模转录组谱揭示了强大的 20 个特征代谢预测模型和 G6PC 在透明细胞肾细胞癌中的新作用。
J Cell Mol Med. 2020 Aug;24(16):9012-9027. doi: 10.1111/jcmm.15536. Epub 2020 Jun 21.
3
Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study.基于深度学习的多模型预测手术后透明细胞肾细胞癌患者无复发生存状态:一项多中心队列研究。
Int J Surg. 2024 May 1;110(5):2970-2977. doi: 10.1097/JS9.0000000000001222.
4
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
5
Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.外泌体相关长链非编码 RNA 评分:一种基于价值的个体化治疗策略,用于预测透明细胞肾细胞癌对免疫治疗的反应。
Cancer Med. 2024 Jun;13(11):e7308. doi: 10.1002/cam4.7308.
6
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.一个与细胞周期相关的新型铁死亡相关基因特征,可用于预测透明细胞肾细胞癌患者的预后。
BMC Cancer. 2022 Jan 3;22(1):1. doi: 10.1186/s12885-021-09033-7.
7
Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.综合多组学鉴定干扰素-γ反应特征表明 RBCK1 调节肾细胞癌的免疫抑制微环境。
Front Immunol. 2021 Nov 2;12:734646. doi: 10.3389/fimmu.2021.734646. eCollection 2021.
8
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.基于铁死亡相关基因特征预测透明细胞肾细胞癌患者的总生存期。
World J Surg Oncol. 2022 Apr 14;20(1):120. doi: 10.1186/s12957-022-02555-9.
9
Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).鉴定转化生长因子β诱导(TGFBI)为透明细胞肾细胞癌(ccRCC)中的一个免疫相关预后因素。
Aging (Albany NY). 2020 May 14;12(9):8484-8505. doi: 10.18632/aging.103153.
10
Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.解析透明细胞肾细胞癌中恶性肿瘤和肿瘤微环境的谷氨酰胺代谢模式。
Clin Exp Med. 2024 Jul 6;24(1):152. doi: 10.1007/s10238-024-01390-4.

引用本文的文献

1
A review of enhanced biosignature immunotherapy tools for predicting lung cancer immune phenotypes using deep learning.利用深度学习预测肺癌免疫表型的增强生物标志物免疫治疗工具综述。
Discov Oncol. 2025 May 30;16(1):966. doi: 10.1007/s12672-025-02771-1.
2
Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma.糖原代谢基因作为透明细胞肾细胞癌亚型分类、预后预测及免疫治疗选择的分子标志物
Clin Exp Med. 2025 Feb 17;25(1):61. doi: 10.1007/s10238-025-01592-4.
3
Three-dimensional deep learning model complements existing models for preoperative disease-free survival prediction in localized clear cell renal cell carcinoma: a multicenter retrospective cohort study.

本文引用的文献

1
Cancer incidence and mortality in China, 2015.2015年中国的癌症发病率和死亡率
J Natl Cancer Cent. 2020 Dec 17;1(1):2-11. doi: 10.1016/j.jncc.2020.12.001. eCollection 2021 Mar.
2
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab.接受伊匹单抗和纳武利尤单抗治疗的转移性肾细胞癌和脑转移患者的临床结局。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-003281.
3
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
三维深度学习模型补充现有模型用于预测局限性透明细胞肾细胞癌的术前无病生存期:一项多中心回顾性队列研究
Int J Surg. 2024 Nov 1;110(11):7034-7046. doi: 10.1097/JS9.0000000000001808.
4
Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images.基于深度学习的原发性全切片图像肾细胞癌患者淋巴结转移的病理预测。
J Transl Med. 2024 Jun 14;22(1):568. doi: 10.1186/s12967-024-05382-6.
5
Applications of artificial intelligence in urologic oncology.人工智能在泌尿肿瘤学中的应用。
Investig Clin Urol. 2024 May;65(3):202-216. doi: 10.4111/icu.20230435.
6
PLM-GAN: A Large-Scale Protein Loop Modeling Using pix2pix GAN.PLM-GAN:一种使用pix2pix生成对抗网络的大规模蛋白质环建模方法
ACS Omega. 2023 Dec 15;9(1):437-446. doi: 10.1021/acsomega.3c05863. eCollection 2024 Jan 9.
7
The Present and Future of Artificial Intelligence in Urological Cancer.人工智能在泌尿系统癌症中的现状与未来
J Clin Med. 2023 Jul 29;12(15):4995. doi: 10.3390/jcm12154995.
8
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.染色体不稳定25基因特征在透明细胞肾细胞癌中被鉴定出来,并可作为生存和舒尼替尼反应的预测指标。
Front Oncol. 2023 May 1;13:1133902. doi: 10.3389/fonc.2023.1133902. eCollection 2023.
9
Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancer.基于深度学习的前列腺癌铁死亡调节因子临床预后综合分析及潜在化疗敏感性分析
Precis Clin Med. 2023 Feb 2;6(1):pbad001. doi: 10.1093/pcmedi/pbad001. eCollection 2023 Mar.
10
RCCC_Pred: A Novel Method for Sequence-Based Identification of Renal Clear Cell Carcinoma Genes through DNA Mutations and a Blend of Features.RCCC_Pred:一种通过DNA突变和特征融合基于序列鉴定肾透明细胞癌基因的新方法。
Diagnostics (Basel). 2022 Dec 3;12(12):3036. doi: 10.3390/diagnostics12123036.
构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
4
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.将 HECW1 表达纳入临床指标可高度准确地评估透明细胞肾细胞癌患者的预后。
BMC Cancer. 2021 Aug 4;21(1):890. doi: 10.1186/s12885-021-08631-9.
5
Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis.非典型 TGF-β 信号通路导致 FBXO3 介导的 ΔNp63α 降解,促进乳腺癌转移和不良临床预后。
PLoS Biol. 2021 Feb 24;19(2):e3001113. doi: 10.1371/journal.pbio.3001113. eCollection 2021 Feb.
6
Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma.用于预测肾细胞癌病理分级的计算机断层扫描影像组学
Front Oncol. 2021 Jan 27;10:570396. doi: 10.3389/fonc.2020.570396. eCollection 2020.
7
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
8
FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells.FBXO44 促进癌细胞中 DNA 复制偶联的重复元件沉默。
Cell. 2021 Jan 21;184(2):352-369.e23. doi: 10.1016/j.cell.2020.11.042. Epub 2020 Dec 23.
9
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.体细胞改变与免疫浸润的相互作用调节晚期透明细胞肾细胞癌对 PD-1 阻断的反应。
Nat Med. 2020 Jun;26(6):909-918. doi: 10.1038/s41591-020-0839-y. Epub 2020 May 29.
10
F-Box Proteins and Cancer.F盒蛋白与癌症
Cancers (Basel). 2020 May 15;12(5):1249. doi: 10.3390/cancers12051249.